You have 9 free searches left this month | for more free features.

Polycythemia Vera

Showing 1 - 25 of 363

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polycythemia Vera Trial (bomedemstat)

Not yet recruiting
  • Polycythemia Vera
  • (no location specified)
Sep 26, 2022

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • (no location specified)
Mar 7, 2022

Polycythemia Vera Trial (SLN124, Placebo)

Not yet recruiting
  • Polycythemia Vera
  • (no location specified)
Aug 10, 2022

Identify and Describe Predictive Factors for Thromboembolic

Not yet recruiting
  • Polycythemia Vera
  • Hydroxyurea
  • Ruxolitinib
  • (no location specified)
Sep 21, 2022

Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Ruxolitinib for Polycythemia Vera in Patients Resistant to or

Completed
  • Polycythemia Vera (PV)
  • Ruxolitinib
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)

Recruiting
  • Phlebotomy Dependent Polycythemia Vera
  • Orange, California
  • +4 more
Aug 1, 2022

Polycythemia Vera Trial in Korea, Republic of, Malaysia (PTG-300)

Active, not recruiting
  • Polycythemia Vera
  • Incheon, Korea, Republic of
  • +7 more
Mar 8, 2022

Polycythemia Vera, Essential Thrombocythemia, and

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Next-generation sequencing
  • (no location specified)
Jun 27, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Ipoh, Perak, Malaysia
    Hospital Raja Permaisuri Bainun
Jul 18, 2022

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

Recruiting
  • Polycythemia Vera
  • London, United Kingdom
  • +1 more
Nov 29, 2021

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Completed
  • Polycythemia Vera (PV)
  • Toon-shi, Ehime, Japan
  • +7 more
Dec 8, 2021

Effect of Phlebotomy on Heartrate in Polycythemia Patients

Not yet recruiting
  • Polycythemia
  • phlebotomy
  • (no location specified)
Jun 2, 2022

Polycythemia Vera Trial in Worldwide (Idasanutlin)

Terminated
  • Polycythemia Vera
  • Phoenix, Arizona
  • +10 more
Dec 7, 2021

Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)

Not yet recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Boston, Massachusetts
  • +2 more
Nov 24, 2020

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

Active, not recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Jan 20, 2022

Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

Recruiting
  • Polycythemia Vera (PV)
  • P1101 (Ropeginterferon alfa-2b)
  • Toon-shi, Ehime, Japan
  • +5 more
Jun 13, 2022

A Prospective, Two-arm, Non-interventional Study of JAKAVIĀ® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021